News & Updates
Filter by Specialty:

Statin-ezetimibe combo superior to monotherapy in preventing CVD in T2D patients
In patients with type 2 diabetes (T2D), moderate-intensity statin in combination with ezetimibe results in greater reductions in low-density lipoprotein cholesterol (LDL-C) and better prevention of adverse outcomes when compared with high-intensity statin monotherapy, suggests a study.
Statin-ezetimibe combo superior to monotherapy in preventing CVD in T2D patients
27 Jun 2024
Self-testing of HbA1c feasible in diabetic patients
Patients with diabetes show high levels of acceptance and ability to adopt self-testing of glycated haemoglobin (HbA1c) despite facing issues in the insertion of test cartridges into the analyser, reports a study. Patients also express willingness to do self-testing in the future if such a service is available.
Self-testing of HbA1c feasible in diabetic patients
26 Jun 2024
Off-label targeted drugs improve survival in CTEPH
Off-label pulmonary arterial hypertension (PAH)-targeted drugs may increase long-term survival in patients with chronic thromboembolic pulmonary hypertension (CTEPH), as shown in a study.
Off-label targeted drugs improve survival in CTEPH
26 Jun 2024
Working out in the COVID aftermath: How intense can one go?
Outpatients with post-COVID condition (PCC) generally tolerated exercise without significant worsening of symptoms or decline in aerobic performance after 48 hours. However, they had lower muscle strength and aerobic capacity than controls, and even showed signs of POTS* and myopathy in a randomized crossover trial.